CD1d positive tumors are more susceptible to iNKT cell-mediated lysis compared to CD1d negative tumors, and cancer cells often avoid detection by downregulating CD1d, demonstrating an important role for CD1d-TCR interactions in immunosurveillance [48,49,50]. The gene discussed is CD1D; the disease is cancer.